drugset / Trial / NCT07567742
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
RandomizedParallel-groupOpen-labelPrevention
Summary
This clinical trial aims to understand whether taurine can prevent and reduce severe radiation-induced oral mucositis in patients with nasopharyngeal carcinoma undergoing radiotherapy.
Timeline
- Start
- 2026-05-06
- Primary completion
- 2027-03-30
- Completion
- 2029-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Taurine | Other / unclassified | 1 g | Oral |